Breast cancer research and inkjet tissue printing get NSF boost

November 05, 2007

CLEMSON -- The National Science Foundation (NSF) has awarded $2 million to the Center for Biological Interfaces of Engineering (CBIOE) at Clemson University for the development of engineered tissues that will be used to study the causes, progression and treatment of breast cancer.

The tissue engineering technology, which was pioneered at Clemson, is based on inkjet printing and will allow the creation of identical tissue samples that can be used to build cause and effect models.

"We will expose these identical tissue models to different environmental conditions to better understand what causes and then stimulates the development of breast cancer. Our research team includes breast cancer surgeons, engineers and scientists - the breadth of expertise is tremendous and absolutely crucial for this very complex problem," said CBIOE director Karen Burg, who will lead the multi-disciplinary research team.

Other collaborating investigators include Steve Ellis and Susan Duckett in animal and veterinary sciences, Thomas Boland in bioengineering, Amy Moran in biological sciences, Jason McNeill in chemistry and Rick Groff and Timothy Burg in electrical and computer engineering. The initiative will benefit from input from CBIOE partnering institutions Carolinas Medical Center, the University of North Carolina at Chapel Hill and the University of North Carolina at Charlotte.

The CBIOE, located in Rhodes Engineering Research Building at Clemson University, is a state approved research and training center. Its mission is to promote the development of clinically relevant biomaterials technology and products for disease treatment and the transfer of this technology for patient care.

The NSF grant was among seven awarded to institutions to advance basic knowledge and control in the area of cellular and biomolecular engineering through the newly established NSF Emerging Frontiers in Research Innovation Office (EFRI). Other institutions receiving EFRI awards are John Hopkins University, University of Maryland, Massachusetts Institute of Technology (MIT), Stanford University, University of Virginia and University of Wisconsin.
-end-


Clemson University

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.